21st Austria weekly - Marinomed voestalpine Frequentis 09/08/2023 [pic1]Marinomed: Austrian biotech company Marinomed Biotech AG has concluded the first long-term Solv4U technology partnership with Shanghai-based SPH Sine Pharmaceutical Laboratories Co. Ltd. SPH Sine. The
EQS-News: Marinomed Biotech AG / Key word: Miscellaneous
Marinomed enters first long-term Solv4U partnership with Shanghaibased SPH Sine Pharmaceutical Laboratories.
EQS-News: Marinomed Biotech AG / Key word(s): MiscellaneousMarinomed enters first long-term Solv4U partnership with Shanghaibased SPH Sine Pharmaceutical Laboratories Co. Ltd. 09.08.2023 / 07:45 CET/CESTThe issuer is solely responsible for the content of this announcement.Marinomed enters first long-term Solv4U part.
21st Austria weekly - Verbund Andritz Amag ams Osram Marinomed 27/07/2023 [pic1]Verbund: Austrian utility Verbund saw an improvement in the results posted for quarters 1–2/2023. The reported Group result rose by 57.5% to €1 287.2m. Generation from annual storage power plants 6.2% 1–2/2023 compared with prior-year reporting period. hydropower thus increased 947 GWh 15 054 GWh. sharp rise wholesale electricity prices on futures markets that were relevant period gave earnings a considerable boost. Conversely spot market fell average sales obtained VERBUND’s own generation €69.6/MWh €182.1/MWh. Higher photovoltaic installations and wind plants especially put into operation Spain also had positive effect as did higher contribution Gas Connect